THE INSTITUTE FOR CANCER RESEARCH
THE INSTITUTE FOR CANCER RESEARCH has won 13 federal awards worth $5.1M in total across 1 agencies, with a median award of $516K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS | Department Of Health And Human Services | $1.0M | 2023-07-07 |
| PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND | Department Of Health And Human Services | $1.2M | 2023-05-01 |
| TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON | Department Of Health And Human Services | $702K | 2022-09-15 |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL | Department Of Health And Human Services | $614K | 2022-06-13 |
| THE ELNITSKI LAB IS PURCHASING NORMAL, LIVER, AND PROSTATE CANCER PATI | Department Of Health And Human Services | $17K | 2021-05-03 |
Questions
How many federal contracts has THE INSTITUTE FOR CANCER RESEARCH won?
13 awards on record, worth $5.1M in total across 1 agency. The median award is $516K.
Which agencies buy from THE INSTITUTE FOR CANCER RESEARCH?
Mostly Department Of Health And Human Services.
Is THE INSTITUTE FOR CANCER RESEARCH a competitor worth watching?
That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.
Agencies they win from
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.